[Polygynax].
D000935:Antifungal Agents / Q000627:therapeutic use*; D001152:Arsenicals / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy* / Q000517:prevention & control; D004338:Drug Combinations; D005260:Female; D006801:Humans; D009355:Neomycin / Q000627:therapeutic use*; D009761:Nystatin / Q000627:therapeutic use*; D011113:Polymyxins / Q000627:therapeutic use*; D014622:Vaginal Creams, Foams, and Jellies / Q000627:therapeutic use*; D016585:Vaginosis, Bacterial / Q000188:drug therapy* / Q000517:prevention & control
D000935:Antifungal Agents; D001152:Arsenicals; D004338:Drug Combinations; D011113:Polymyxins; D014622:Vaginal Creams, Foams, and Jellies; D009761:Nystatin; C006119:acetarsol, dimethicone, neomycin, nystatin, polymyxin drug combination; D009355:Neomycin